The generic name of Baixin Tong is Nifedipine Controlled-Release Tablets, which can be used in combination with hydrochlorothiazide, valsartan and other drugs to treat high blood pressure with good antihypertensive effect. It should be used according to the specific condition and under the guidance of the doctor, and should not be used without authorization.
Nifedipine controlled-release tablets are dihydropyridine calcium channel antagonists, which can dilate coronary and peripheral resistance vessels, and can treat hypertension, chronic stable angina and coronary heart disease.
In the treatment of hypertension, nifedipine controlled-release tablets can be used in combination with diuretics hydrochlorothiazide, angiotensin receptor antagonists such as valsartan, and angiotensin-converting enzyme inhibitors such as Benadryl, etc., which have synergistic blood pressure-lowering effects.
In the treatment of angina pectoris, nifedipine controlled-release tablets are suitable for the synergistic treatment of patients with angina pectoris accompanied by hypertension with beta-blockers such as metoprolol, etc. In addition, antiplatelet drugs such as aspirin, clopidogrel, and lipid-regulating drugs such as atorvastatin can also be used in combination to improve the prognosis.
Adverse reactions such as dizziness and headache, fever, palpitation, edema, nausea and heartburn may occur during use.
Nifedipine controlled-release tablets are contraindicated in people with a history of allergy to the components of this drug, cardiogenic shock, and pregnant women within 20 weeks of pregnancy, lactating women, etc., and can not be used in combination with rifampicin.
Nifedipine controlled-release tablets should be used under the guidance of a doctor, if there is any discomfort in the use of immediate medical attention.